TGA Approval

APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial (377474)

ARTG ID

377474

ARTG Name

APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial

Sponsor

ViiV Healthcare Pty Ltd

ARTG Date

August 11, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

VIIV HEALTHCARE PTY LTD

https://medical-cdn.nocode.com/drug_tga/dd7c54c7d7a582a925e6fb5bfd086728.pdf

https://medical-cdn.nocode.com/drug_tga/6ffb93ccc46350b53298326d00e78dd5.pdf

Ingredient Name

cabotegravir

Empowering clinical research with data-driven insights and AI-powered tools.

APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vial (377474) - TGA 批准文号 | MedPath